HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra.

AbstractBACKGROUND AND PURPOSE:
Release of excitatory amino acids (EAA) is considered a cause of neuronal damage in ischemia. We investigated the sources and mechanisms of EAA release using microdialysis in regions of incomplete ischemia where perfusion was reduced by 50% to 80%, by applying inhibitors of volume-regulated anion channels (VRACs) and the GLT-1 glutamate transporter.
METHODS:
Reversible middle cerebral artery occlusion (rMCAo) was induced in anesthetized rats using the intraluminal suture technique. Microdialysate concentrations of glutamate, aspartate, and taurine were measured before, during 2 hours of rMCAo, and for 2 hours after rMCAo. Vehicle, dihydrokainate (DHK, 1 mmol/L), a GLT-1 inhibitor, or tamoxifen (50 micromol/L), a VRAC inhibitor, were administered continuously via the dialysis probes starting one hour prior to ischemia.
RESULTS:
During incomplete ischemia, dialysate glutamate levels averaged 1.74+/-0.31 micromol/L (SEM) in the control group (n=8), 2.08+/-0.33 micromol/L in the DHK group (n=7), and were significantly lower at 0.88+/-0.30 micromol/L in the tamoxifen group (n=9; P<0.05). As perfusion returned toward baseline levels, EAA levels declined in the vehicle and tamoxifen-treated animals but they remained elevated in the DHK-treated animals.
CONCLUSIONS:
In contrast to previous results in severely ischemic regions, DHK did not reduce EAA release in less severely ischemic brain, suggesting a diminished role for transporter reversal in these areas. These findings also support the hypothesis that in regions of incomplete ischemia, release of EAAs via VRACs may play a larger role than reversal of the GLT-1 transporter.
AuthorsPaul J Feustel, Yiqiang Jin, Harold K Kimelberg
JournalStroke (Stroke) Vol. 35 Issue 5 Pg. 1164-8 (May 2004) ISSN: 1524-4628 [Electronic] United States
PMID15017010 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Amino Acid Transport System X-AG
  • Anion Transport Proteins
  • Excitatory Amino Acids
  • Receptors, Glutamate
  • Tamoxifen
  • Taurine
  • Aspartic Acid
  • Glutamic Acid
  • dihydrokainic acid
  • Kainic Acid
Topics
  • Amino Acid Transport System X-AG
  • Animals
  • Anion Transport Proteins (metabolism)
  • Aspartic Acid (metabolism)
  • Astrocytes (metabolism)
  • Brain Ischemia (metabolism)
  • Cerebral Cortex (metabolism)
  • Excitatory Amino Acids (metabolism)
  • Glutamic Acid (metabolism)
  • Infarction, Middle Cerebral Artery
  • Kainic Acid (analogs & derivatives, pharmacology)
  • Microdialysis
  • Neurons (metabolism)
  • Rats
  • Receptors, Glutamate (metabolism)
  • Tamoxifen (pharmacology)
  • Taurine (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: